Patent Assignment
Reel/Frame 036653/0065
Security Interest
Recorded: 2015-09-25
Pages: 12
Assignor
AMAG PHARMACEUTICALS, INC.
Executed: 2015-08-17
Assignee
JEFFERIES FINANCE LLC
520 MADISON AVENUE, NEW YORK, NEW YORK, 10022
Covered Properties
(27)
Vascular Magnetic Imaging Method and Agent Comprising Biodegradeable Superparamagnetic Metal Oxides
Patent:
5,055,288 →
Application:
07/233,177 →
Biodegraduble Superparamagnetic Metal Oxides as Contrast Agents for Mr Imaging
Patent:
4,951,675 →
Application:
07/244,432 →
Silanized Biodegradable Superparamagnetic Metal Oxides as Contrast Agents for Imaging the Gastroinestinal Tract
Patent:
5,069,216 →
Application:
07/409,384 →
Low Molecular Weight Carbohydrates as Additives to Stabilize Metal Oxide Compositions
Patent:
5,102,652 →
Application:
07/475,618 →
Filter Sterilization for Production of Colloidal, Superparamagnetic Mr Contrast Agents
Patent:
5,160,726 →
Application:
07/650,957 →
Synthesis of Polysaccharide Covered Superparamagnetic Oxide Colloids
Patent:
5,262,176 →
Application:
07/694,636 →
Low Molecular Weight Carbohydrates as Additives to Stabilize Metal Oxide Compositions
Patent:
5,248,492 →
Application:
07/860,388 →
Hydrated Biodegradable Superparamagnetic Metal Oxides
Patent:
5,219,554 →
Application:
07/863,360 →
Arabinogalactan Derivatives and Uses Thereof
Patent:
5,478,576 →
Application:
07/900,686 →
Asialoglycoprotein Receptor Specific Compostions and Their Use as Mri Contrast Agents
Patent:
5,352,432 →
Application:
07/917,567 →
Receptor Mediated Endocytosis Type Magnetic Resonance Imaging Contrast Agents
Patent:
5,342,607 →
Application:
07/924,121 →
Targeting of Therapeutic Agents Using Polysaccharides
Patent:
5,336,506 →
Application:
07/936,873 →
Vascular Magnetic Resonance Imaging Method Comprising Nanoparticles
Patent:
5,314,679 →
Application:
07/995,111 →
Directed Delivery of Radioprotectants Using a Receptor Specific Carrier
Patent:
5,490,991 →
Application:
08/043,611 →
Delivery of Therapeutic Agents to Receptors Using Polysaccharides
Patent:
5,554,386 →
Application:
08/260,551 →
Endotoxin-Free Polysaccharides
Patent:
5,589,591 →
Application:
08/346,142 →
Hepatocyte-Specific Receptor-Mediated Endocytosis-Type Compositions Contrast Agents
Patent:
5,679,323 →
Application:
08/444,136 →
Polymeric Carriers Linked to Nucleotide Analogues via a Phosphoramide Bond
Patent:
5,981,507 →
Application:
08/766,597 →
Heat Stable Colloidal Iron Oxides Coated with Reduced Carbohydrates and Carbohydrate Derivatives
Patent:
6,599,498 →
Application:
09/521,264 →
Heat Stable Colloidal Iron Oxides Coated with Reduced Carbohydrates and Uses Thereof
Polyol and Polyether Iron Oxide Complexes as Pharmacological and/or Mri Contrast Agents
Macrophage-Enhanced MRI (MEMRI)
Application:
12/145,565 →
Publication:
US 2009/0004113
Polyol and Polyether Iron Oxide Complexes as Pharmacological and/or Mri Contrast Agents
Macrophage-Enhanced MRI (MEMRI) in a Single Imaging Session
Application:
13/197,153 →
Publication:
US 2012/0003160
Polyol and Polyether Iron Oxide Complexes as Pharmacological and/or MRI Contrast Agents
Polyol and Polyether Iron Oxide Complexes as Pharmacological and/or MRI Contrast Agents
Polyol and Polyether Iron Oxide Complexes as Pharmacological and/or MRI Contrast Agents
Related Assignments
(11)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest
Nov 12, 2014
From: AMAG PHARMACEUTICALS, INC.
To: JEFFERIES FINANCE LLC
Reel/Frame 034156/0214 →
Release of Security Interest
May 15, 2017
From: JEFFERIES FINANCE LLC
To: AMAG PHARMACEUTICALS, INC.
Reel/Frame 042459/0824 →
Assignment of Assignor's Interest
Feb 12, 2021
From: AMAG PHARMACEUTICALS, INC.
To: COVIS PHARMA GMBH
Reel/Frame 055241/0517 →
Security Interest
Feb 22, 2021
From: COVIS PHARMA GMBH
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 055354/0063 →
Corrective Assignment to Correct the Correspondence Address Previously Recorded at Reel: 055241 Frame: 0517. Assignor(S) Hereby Confirms the Assignment.
Feb 23, 2021
From: AMAG PHARMACEUTICALS, INC.
To: COVIS PHARMA GMBH
Reel/Frame 055363/0746 →
Assignment of Assignor's Interest
Apr 30, 2021
From: AMAG PHARMACEUTICALS, INC.
To: COVIS PHARMA GMBH
Reel/Frame 056100/0388 →
Notice of Grant of Security Interest in Intellectual Property (First Lien)
Jan 4, 2022
From: COVIS PHARMA GMBH
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 058640/0787 →
Release of Security Interest
Feb 18, 2022
From: CAPITAL ONE, NATIONAL ASSOCIATION
To: COVIS PHARMA GMBH
Reel/Frame 059043/0226 →
Notice of Grant of Security Interest in Intellectual Property (Second Lien)
Feb 18, 2022
From: COVIS PHARMA GMBH
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 059232/0514 →
Release of Security Interest
Jun 2, 2023
From: BARCLAYS BANK PLC
To: COVIS PHARMA GMBH
Reel/Frame 063841/0208 →
Release of Security Interest in Patents
Mar 17, 2025
From: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: COVIS PHARMA GMBH
Reel/Frame 070537/0122 →